Philadelphia Trust Co. Invests $59,000 in Liquidia Co. (NASDAQ:LQDA)

Share on StockTwits

Philadelphia Trust Co. acquired a new stake in Liquidia Co. (NASDAQ:LQDA) during the fourth quarter, Holdings reports. The firm acquired 20,000 shares of the company’s stock, valued at approximately $59,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Squarepoint Ops LLC grew its holdings in Liquidia by 115.7% during the third quarter. Squarepoint Ops LLC now owns 36,173 shares of the company’s stock valued at $178,000 after purchasing an additional 19,404 shares during the last quarter. AQR Capital Management LLC bought a new stake in shares of Liquidia during the 3rd quarter worth $91,000. California State Teachers Retirement System boosted its holdings in shares of Liquidia by 33.6% during the 3rd quarter. California State Teachers Retirement System now owns 40,998 shares of the company’s stock worth $202,000 after buying an additional 10,300 shares during the period. BlackRock Inc. grew its stake in Liquidia by 18.7% in the 3rd quarter. BlackRock Inc. now owns 1,445,043 shares of the company’s stock valued at $7,110,000 after buying an additional 227,494 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in Liquidia by 82.3% in the 2nd quarter. Bank of America Corp DE now owns 9,184 shares of the company’s stock worth $77,000 after acquiring an additional 4,146 shares during the period. Hedge funds and other institutional investors own 36.49% of the company’s stock.

In related news, major shareholder Eshelman Ventures, Llc sold 51,906 shares of the stock in a transaction dated Monday, December 21st. The shares were sold at an average price of $3.13, for a total value of $162,465.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders sold 1,512,042 shares of company stock valued at $4,538,503. Corporate insiders own 4.30% of the company’s stock.

A number of research firms have issued reports on LQDA. Zacks Investment Research cut shares of Liquidia from a “buy” rating to a “hold” rating in a report on Saturday, January 16th. Wedbush restated a “hold” rating and set a $4.00 target price on shares of Liquidia in a research note on Monday, November 30th. Finally, HC Wainwright started coverage on Liquidia in a research report on Friday, December 4th. They issued a “buy” rating and a $6.00 price target on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Liquidia currently has an average rating of “Buy” and an average target price of $15.45.

Shares of LQDA opened at $3.44 on Tuesday. The company has a 50-day simple moving average of $3.09 and a 200-day simple moving average of $3.95. The firm has a market capitalization of $149.08 million, a P/E ratio of -1.62 and a beta of 0.05. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.67 and a current ratio of 5.67. Liquidia Co. has a 52 week low of $2.53 and a 52 week high of $12.10.

Liquidia Profile

Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company. The company focuses on the development and commercialization of various products using its PRINT technology that enables precise production of drug particles designed to enhance the safety, efficacy, and performance of a range of therapies.

Recommended Story: Balanced Fund

Want to see what other hedge funds are holding LQDA? Visit to get the latest 13F filings and insider trades for Liquidia Co. (NASDAQ:LQDA).

Institutional Ownership by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with's FREE daily email newsletter.